Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating diabetic retinopathy and preparation method thereof

A technology for retinopathy and diabetes, which is applied in the field of pharmaceutical compositions for the treatment of diabetic retinopathy and the preparation thereof, can solve problems such as large side effects and deepen the suffering of patients, and can reduce hyperglycemia, improve glucose metabolism, and improve human immunity. Effect

Inactive Publication Date: 2016-07-06
孔德华
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most of the current medicines for treating diabetes are western medicine antibiotics, which have great side effects. For diabetic patients with poor physical condition, it has deepened the suffering of patients from another level. So how to develop a drug that can effectively control blood sugar and reduce complications? Drugs with a higher probability of seizures and less side effects are the direction we want to study

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] A pharmaceutical composition for treating diabetic retinopathy, which is composed of the following ingredients in parts by weight: 40 parts of coarse grain mixed powder, 35 parts of hibiscus bark acetic acid, 33 parts of p-chlorophenoxyisobutyric acid, 31 parts of syringin, algae 26 parts of cyanine, 19 parts of untethered terpene, 16 parts of stigmasterol, 13 parts of formononetin, 10 parts of L-α-aminoadipic acid, 8 parts of pancreatic enzyme, 7 parts of L-malic acid, 0.05 part of vitamin , 0.004 parts of L-glutamic acid.

[0018] The preparation method of this pharmaceutical composition is:

[0019] Step 1: Mix coarse grain powder, hibiscus bark acetic acid, p-chlorophenoxyisobutyric acid, syringin, phycocyanin, terpene, stigmasterol, formononetin, L-α -Aminoadipic acid, L-malic acid, vitamins, and L-glutamic acid are mixed evenly with a blender, crushed into fine powder with a heavy pressure grinder, passed through a 300-mesh sieve, and then evenly sprinkled with p...

Embodiment 2

[0023] A pharmaceutical composition for treating diabetic retinopathy, which is composed of the following components by weight: 54 parts of coarse grain mixed powder, 47.5 parts of hibiscus bark acetic acid, 45 parts of p-chlorophenoxyisobutyric acid, 43 parts of syringin, algae 38 parts of cyanine, 27.5 parts of untethered terpene, 23 parts of stigmasterol, 20 parts of formononetin, 16.5 parts of L-α-aminoadipic acid, 14 parts of pancreatic enzyme, 12.5 parts of L-malic acid, 0.1 part of vitamin , 0.007 parts of L-glutamic acid.

[0024] The preparation method of this pharmaceutical composition is:

[0025] Step 1: Mix coarse grain powder, hibiscus bark acetic acid, p-chlorophenoxyisobutyric acid, syringin, phycocyanin, terpene, stigmasterol, formononetin, L-α -Aminoadipic acid, L-malic acid, vitamins, and L-glutamic acid are mixed evenly with a mixer, crushed into fine powder with a heavy-pressure grinder, passed through a 350-mesh sieve, and then evenly sprinkled with panc...

Embodiment 3

[0029] A pharmaceutical composition for treating diabetic retinopathy, which is composed of the following ingredients in parts by weight: 68 parts of coarse grain mixed powder, 60 parts of hibiscus bark acetic acid, 57 parts of p-chlorophenoxyisobutyric acid, 55 parts of syringin, algae 50 parts of cyanine, 36 parts of untethered terpene, 30 parts of stigmasterol, 27 parts of formononetin, 23 parts of L-α-aminoadipic acid, 20 parts of pancreatic enzyme, 18 parts of L-malic acid, 0.15 parts of vitamin , 0.01 parts of L-glutamic acid.

[0030] The preparation method of this pharmaceutical composition is:

[0031] Step 1: Mix coarse grain powder, hibiscus bark acetic acid, p-chlorophenoxyisobutyric acid, syringin, phycocyanin, terpene, stigmasterol, formononetin, L-α -Aminoadipic acid, L-malic acid, vitamins, and L-glutamic acid are mixed evenly with a mixer, crushed into fine powder with a heavy pressure grinder, passed through a 400-mesh sieve, and then evenly sprinkled with p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating diabetic retinopathy and a preparation method thereof. The pharmaceutical composition for treating diabetic retinopathy consists of the following components in parts by weight: coarse grain mixed powder, pseudolaric acid, p-chlorophenoxy isobutyric acid, syringin, phycocyanobilin, friedelin, stigmasterol, formononetin, L-alpha-aminoadipic acid, pancreatin, L-malic acid, vitamin and L-glutamic acid. The pharmaceutical composition disclosed by the invention realizes the effects of controlling blood glucose and treating retinopathy by improving glycometabolism, focusing on blood glucose reduction assisted by the medicinal components for nourishing yin and clearing heat and resolving stasis and by improving the human immunity to enhance the tolerance and resistance against lesion; and moreover, the pharmaceutical composition is simple in technology, realizes a good curative effect and can be promoted for application.

Description

technical field [0001] The invention relates to the technical field of diabetes medication, in particular to a pharmaceutical composition for treating diabetic retinopathy and a preparation method thereof. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by hyperglycemia caused by multiple etiologies. Hyperglycemia is caused by defective insulin secretion or impaired biological action, or both. Long-term high blood sugar leads to chronic damage and dysfunction of various tissues, especially the eyes, brain, kidney, heart, blood vessels, and nerves. As a high-incidence disease, diabetes has been difficult to be completely cured. The difficulty is not only the high blood sugar in diabetes itself, which makes it difficult to control it well, but also the complex and changeable complications it causes. According to the statistics of the World Health Organization, diabetes There can be more than 100 kinds of complications, and once the complic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/54A61K36/899A61K31/19A61K31/192A61K31/7034A61K31/409A61K31/56A61K31/575A61K31/352A61K31/198A61K31/14A61K31/51A61K31/07A61K31/7048A61P3/10A61P9/10A61P9/00A61P31/00A61P29/00A61P37/04A61P27/02
CPCA61K38/54A61K9/2059A61K31/07A61K31/14A61K31/19A61K31/192A61K31/198A61K31/352A61K31/409A61K31/51A61K31/56A61K31/575A61K31/7034A61K31/7048A61K36/899C12Y301/01003C12Y304/21004A61K2300/00
Inventor 孔德华
Owner 孔德华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com